Citius Pharmaceuticals Inc. Common Stock (CTXR)

Stock · NASDAQ · Health Care

$0.602as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$0.547

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

CTXR
Citius Pharmaceuticals Inc. Common Stock
$0.602
▼ 4.29%
Market cap $16.36MP/E —
MDCX
Medicus Pharma Ltd. Common Stock
$0.258
▼ 3.73%
Market cap $16.60MP/E —
$0.2425$3.05
OPTH
Optimi Health Corp. Common Shares
$4.93
▼ 0.80%
Market cap $16.61MP/E —
$0.195$11.4
LPCN
Lipocine Inc. Common Stock
$2.2
▼ 1.35%
Market cap $17.40MP/E —
$1.81$12.37
KALA
KALA BIO Inc. Common Stock
$0.6949
▼ 14.42%
Market cap $15.14MP/E —
$0.5867$1,030
CYCN
Cyclerion Therapeutics Inc. Common Stock
$3.81
▼ 4.51%
Market cap $15.11MP/E —
$1.03$8.48
NRSN
NeuroSense Therapeutics Ltd. Ordinary Shares
$0.4301
▼ 2.03%
Market cap $17.64MP/E —
$0.25$1.98

Symbol	Market cap	P/E ratio	Price	1D	52-week range
CTXR Citius Pharmaceuticals Inc. Common Stock	$16.36M	—	$0.602	▼ 4.29%
MDCX Medicus Pharma Ltd. Common Stock	$16.60M	—	$0.258	▼ 3.73%	$0.2425$3.05
OPTH Optimi Health Corp. Common Shares	$16.61M	—	$4.93	▼ 0.80%	$0.195$11.4
LPCN Lipocine Inc. Common Stock	$17.40M	—	$2.2	▼ 1.35%	$1.81$12.37
KALA KALA BIO Inc. Common Stock	$15.14M	—	$0.6949	▼ 14.42%	$0.5867$1,030
CYCN Cyclerion Therapeutics Inc. Common Stock	$15.11M	—	$3.81	▼ 4.51%	$1.03$8.48
NRSN NeuroSense Therapeutics Ltd. Ordinary Shares	$17.64M	—	$0.4301	▼ 2.03%	$0.25$1.98

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.